En Es
Categories

Industry News

Health Summit to Play Greater Role in Chinese Health Industry

By HospiMedica International staff writers
08 May 2018

Image: The Health Industry Summit 2018 covered the entire industry value chain, including key segments such as medical devices, pharmaceutical production, drug distribution and natural health and nutrition (Photo courtesy of tHIS).The Health Industry Summit (tHIS) 2018 held at the National Exhibition and Convention Center in Shanghai on April 11, 2018, was the largest gathering of healthcare industry professionals in the world with well over 200,000 attendees from more than 150 countries and regions and over 7,000 exhibitors. The fourth edition of tHIS covered an exhibition space of over 350,000 square meters with 160 individual events and conferences being held alongside the main expo.

tHIS 2018 is fast becoming China's solution for promoting technology innovations and academic exchange in the medical healthcare arena. China is the second-largest healthcare market in the world and is one of the most attractive in the world for foreign investors. A recent report from McKinsey & Co. estimates China's healthcare market to grow at an unprecedented CAGR of about 12% from USD 357 billion in 2011 to reach USD 1 trillion by 2020. The growth of the Chinese healthcare market is expected to be driven mainly by the country’s ageing population, rise in incidences of lifestyle related diseases such as diabetes and cancer, and major steps taken by the government to improve the local healthcare infrastructure. Recent regulatory changes by the Chinese government are expected to speed up the approvals of medicines and medical devices, thus easing the process of introducing new treatments to the market.

Additionally, under its “Made in China 2025” plan, the Chinese government is focusing on the development of high-performance devices such as diagnostic imaging equipment, robotic surgery devices, high-end medical consumables, including fully degradable cardiovascular stents, wearable devices, and telemedicine. With local companies increasing their technological capabilities and producing high-end medical devices, China’s medical device market will continue to strengthen even as the competition between the players intensifies.

In line with the call by Chinese President Xi for greater promotion of the country’s health industry at the Boao Forum for Asia, tHIS 2018 covered the entire industry value chain, including key segments such as medical devices, pharmaceutical production, drug distribution and natural health and nutrition. The key events at the four-day summit included China's top medical equipment and pharmaceutical exhibitions CMEF, PHARMCHINA and API China, which showcased cutting-edge technologies such as virtual reality, augmented reality, wearables and artificial intelligence as part of the new Intelligent Health exhibition. The show also highlighted traditional medicine as China's own solutions for treatment and prevention, which runs parallel to modern medicine and drug development.

Various medical device giants such as GE, United Imaging, Siemens, Philips and Mindray as well as major pharmaceutical groups in China including Sinopharm, Shanghai Pharma and CR Pharmaceuticals used the show as a platform to launch more than 600 new products for the global or Asia Pacific markets.

tHIS 218 was hosted by Reed Sinopharm, a joint venture between the world's leading event organizer Reed Exhibitions and China's state-owned medical & pharmaceutical giant Sinopharm. The next edition of the event is scheduled to be held in May 2019 in Shanghai.

Related Links:
Reed Exhibitions



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

19 Jul 2018
Global Ambulatory Surgical Centers Market to Reach USD 97 Billion by 2024
The global ambulatory surgical centers (ASCs) market is estimated to have been valued at USD 77.1 billion in 2017 and is expected to grow at a CAGR of 3.5% to reach USD 97.3 billion by 2024, driven mainly by the growing number of surgeries performed in ASCs and increasing accidental cases. Some key advantages of using ASCs such as the personal attention received by patients and lack of exposure to a wide range of infections will also aid the market growth over the coming years.
Read More
19 Jul 2018
Global Critical Care Diagnostics Market to Reach USD 1.3 Billion by 2024
The global critical care diagnostics (CCD) market is estimated to have been valued at USD 837.6 million in 2015 and is expected to reach USD 1.3 billion by 2024, driven by increasing awareness among physicians, patients’ requirements for cost-efficient, rapid, and accurate diagnostic tests, and technological advancements. However, the high costs of these tests and scarcity of skilled labor for handling new platforms pose a challenge to the market growth.
Read More
16 Jul 2018
Guerbet and IBM Watson Health to Jointly Develop AI Software
Guerbet, which specializes in contrast agents and solutions for diagnostic and interventional medical imaging, has signed an agreement with IBM Watson Health to jointly develop an artificial intelligence (AI) software solution for supporting liver cancer diagnostics and care.
Read More
12 Jul 2018
Global Surgical Tables and Lights Market to Surpass USD 1.8 Billion by 2026
The global surgical tables and lights market was valued at more than USD 1.30 billion in 2017 and is projected to grow at a CAGR of over 3.0% over 2018 to 2026 to surpass USD 1.80 billion by 2026. The demand for surgical tables and lights during the forecast period is likely to be driven by developing health care infrastructure in the emerging countries and the introduction of technologically-advanced surgical tables and lights by the market players. However, constant evolution in the surgical tables and lights segment, with the introduction of new features and designs has led to high prices of these products, thereby acting as a major restraint to the market growth.
Read More
12 Jul 2018
Global Endoscopy Ultrasound Market to Reach USD 1 Billion by 2026
The global endoscopy ultrasound market was valued at approximately USD 650 million in 2017 and is expected to grow at a CAGR of over 5.0% from 2018 to 2026 to reach USD 1.0 billion by 2026. The market growth is being driven by an increase in the incidence of gastrointestinal (GI) cancers, rise in endoscopy ultrasound applications as a diagnostic and therapeutic tool for GI cancers and other pancreatic conditions, and growing number of new and advanced products introduced in the global market. However, the lack of training and educational programs conducted and implemented globally is leading to a shortage of adequately trained professionals who are adept at performing endoscopy ultrasound techniques. This has resulted in a gap between demand for and supply of endoscopy ultrasound procedures globally, thereby restraining market growth.
Read More
10 Jul 2018
Global Contrast Injectors Market Driven by Increasing Chronic Diseases
The global contrast injectors market is expected to grow at a CAGR of 5.07% over the forecast period 2018-2022, driven primarily by increasing chronic diseases. In recent years, there has been a significant increase in the demand for medical devices such as contrast injectors for treating such chronic illness arising from the growing incidence of cardiovascular diseases as a result of obesity and increase in blood pressure. These are the latest findings of Research and Markets, a global market research company.
Read More
05 Jul 2018
EKF Diagnostics Releases Educational Guide to Good Capillary Blood Sampling
Global in vitro diagnostics company EKF Diagnostics has published an educational guide, which provides a quick overview of capillary blood sampling best practice. The new guide aims to help health care professionals understand the common causes of pre-analytical errors and reduce their impact on hemoglobin results.
Read More
05 Jul 2018
New AI Software Could Reduce Patient Time at Hospitals
Canadian researchers have developed an innovative "virtual assistant" — an Artificial Intelligence (AI) health monitoring solution for an existing secure health monitoring platform — to help patients, their healthcare providers, and caregivers remotely manage chronic conditions such as diabetes, hypertension, and heart failure. The virtual assistant, developed by the National Research Council of Canada and Greybox Solutions Inc. aims to reduce the considerable time spent in hospitals and healthcare centers by millions of Canadians affected by chronic illnesses.
Read More
04 Jul 2018
Researchers Use AI to Improve Mammogram Interpretation
A team of researchers at the Department of Energy’s Oak Ridge National Laboratory successfully used artificial intelligence to improve understanding of the cognitive processes involved in image interpretation. Their work, which was published in the Journal of Medical Imaging, will help reduce errors in the analyses of diagnostic images by health professionals and has the potential to improve health outcomes for women affected by breast cancer.
Read More
Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions